Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands
GLP-1 medications like Ozempic and Wegovy are transforming consumer eating habits, boosting demand for high-fiber, high-protein, and low-sugar grain-based bakery products. As adoption grows, companies like Ardent Mills are pioneering benefit-stacking strategies to align bakery innovations with the nutritional priorities of GLP-1 users, who experience reduced "food noise," cravings, and appetite. This comprehensive guide explores how these shifts create both challenges and opportunities in the food and beverage (F&B) landscape.
The Impact of GLP-1 Medications on Food and Bakery Consumption
Rising GLP-1 use is notably influencing food and drink innovation across categories, including bakery, where new product development (NPD) opportunities abound. GLP-1 receptor agonists work by mimicking the GLP-1 hormone, which regulates blood sugar, slows gastric emptying, and signals fullness to the brain. This leads to smaller portions and a preference for nutrient-dense foods that support satiety, muscle maintenance, digestive health, and weight management—key concerns for users managing metabolic health.
Due to reduced appetite, GLP-1 users cut back on snacks and indulgent foods, opting for products with better nutritional profiles. Matt Schueller, director of marketing insights at Ardent Mills, highlights these shifts in bread, bakery, cereal, and snacks. "According to our proprietary research, as many as one in ten adults could be taking a GLP-1. This is projected to reduce total adult caloric intake by 1.5 to 2.1% and, according to KPMG, to drive an estimated US$48 billion in annual reductions in F&B spending through 2034. For grain-based categories, this creates both pressure and opportunity," he tells Food Ingredients First.
Why Nutrient Density Matters for GLP-1 Users
GLP-1 therapies enhance insulin sensitivity and promote gradual weight loss, but users often prioritize foods that prevent muscle loss and sustain energy. High-fiber and protein-rich options help by promoting prolonged fullness and gut health, complementing the medications' effects on metabolic pathways. Ardent Mills' research shows GLP-1 users seek high fiber (78%), high nutrients (78%), low carbohydrates (73%), and high plant protein (61%)—preferences that align with broader wellness trends.
Ardent Mills' Benefit-Stacking Approach
Benefit-stacking involves combining fiber, plant protein, and whole grains in familiar bakery formats to deliver multiple nutritional benefits per serving. This strategy upgrades products for GLP-1-driven needs while preserving taste and texture. "Brands can capture share by reformulating with nutrient-dense ingredients. The shift is about upgrading products through ‘benefit-stacking,’ combining fiber, plant protein, and whole grains to support satiety and digestive health. By adding multiple nutritional benefits to familiar formats, brands can increase value per serving while maintaining the taste and texture consumers expect," Schueller explains.
"We advise our customers to anchor innovation in universal nutritional benefits so they can address GLP-1-driven needs while maintaining mainstream appeal." Importantly, fiber demand extends beyond GLP-1 users—more than 50% of consumers are willing to pay more for high-fiber grain-based foods, supporting long-term category growth.
"Our research indicates that GLP-1 users prioritize satiety, muscle maintenance, digestive health, and weight management support. While motivations may vary by life stage, the formulation implications are consistent: nutrient density per bite matters more than ever."
— Matt Schueller, Ardent Mills
This drives innovation toward ingredients delivering concentrated nutrition without compromising sensory quality. Smaller portions must satisfy, making functional whole grains and pulses ideal for fiber and protein delivery.
Key Innovations from Ardent Mills' Portfolio
UltraGrain 100% Whole Wheat Flour
Ardent Mills' portfolio aligns perfectly with this evolution. "An example is our UltraGrain 100% whole wheat flour, which delivers whole grain nutrition with the taste, texture, and color consumers prefer, enabling fiber-forward reformulations," Schueller says. Used in high-fiber sandwich breads, it maintains softness and preferred texture, ideal for GLP-1 users seeking portion-controlled, nutrient-dense options.
Precision tracking for your journey
Join thousands using Shotlee to accurately track GLP-1 medications and side effects.
📱 Get the Shotlee App
Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!
Chickpea Flour and Snacks
Chickpeas are gaining traction for "better-for-you" products, especially with GLP-1 demand. Their gluten-free profile, fiber content, and nutty flavor appeal to weight-loss consumers craving indulgence without guilt. "Another example is our work with chickpeas and chickpea flour, which offer a good source of fiber and a gluten-free alternative, highly versatile ingredient profile. GLP-1 users are contributing to incremental demand, particularly in snack applications, where satiety and nutrient density matter," Schueller notes.
"By incorporating chickpea-based solutions alongside whole grains, brands can develop nutrient-dense products that align with evolving dietary patterns while maintaining flavor and functionality." Examples include snack crackers, crisps, and whole grain tortillas optimized for nutrient density and portion control.
Additional Formulations and Support
Ardent Mills has developed meal-replacement snack formats, prioritized by 61% of GLP-1 users, and bakery products balancing fiber and protein. "The key is balance. Fiber and protein inclusion must be calibrated to avoid density or dryness. Our technical teams help brands optimize hydration, structure, and sensory performance," Schueller adds.
For GLP-1 users tracking their metabolic health, apps like Shotlee can help monitor intake of these high-fiber, protein-rich foods alongside medication effects, ensuring balanced nutrition.
Labeling Challenges and Regulatory Considerations
Communicating "GLP-1-friendly" positioning is tricky without regulatory approval. No official permission exists for "GLP-1" or "GLP-1-friendly" claims on products referencing the medication's benefits, as this could imply drug-like effects. In the US, FDA approval is required; in the EU, EFSA authorization.
Brands can use approved claims like "high in protein," "high in fiber," or "low in sugar" to signal appeal. As GLP-1 adoption grows, pressure for regulatory changes may mount, but caution is advised.
Future Outlook for Grain-Based Categories
The GLP-1 movement is reshaping bakery by curbing indulgent products but opening high-value segments. "GLP-1 medications will continue to shape the grain, flour, and pulse categories in the years ahead," Schueller notes. "The food industry is at a crossroads. As GLP-1 adoption expands, we expect sustained pressure on low-fiber, high-sugar formulations and accelerated demand for nutrient-dense, functional ingredients. Whole grains and pulses will likely gain share as brands seek naturally fiber-rich and protein-forward solutions."
"Grains are not losing relevance—they are evolving to meet new expectations. Ardent Mills is positioned to help customers move food forward by combining grain science, consumer insight, and scalable ingredient solutions. The brands that innovate strategically now will be the best positioned to capture this next phase of growth."
Key Takeaways for Brands and GLP-1 Users
- Consumer Priorities: High fiber (78%), nutrients (78%), low carbs (73%), plant protein (61%) drive reformulation.
- Benefit-Stacking Wins: Combine whole grains, pulses for satiety and health support without sensory trade-offs.
- Innovation Examples: UltraGrain breads, chickpea snacks, nutrient-dense tortillas.
- Market Impact: 1 in 10 adults on GLP-1; $48B F&B spend reduction by 2034.
- For Patients: Discuss high-fiber bakery options with your doctor to complement GLP-1 therapy; track progress with tools like Shotlee for symptoms and nutrition.
What This Means for Metabolic Health and Bakery Innovation
Ardent Mills exemplifies how the bakery sector can thrive amid GLP-1 shifts by prioritizing nutrient density. For those on GLP-1 medications managing metabolic health, these products offer practical ways to sustain muscle mass and digestive wellness. Brands innovating now will lead in a market valuing quality over quantity. Stay informed on related topics like GLP-1 side effects management and peptide therapy nutrition guides.






